Abbott (ABT) stock jumps 12% after beating Q2 2026 earnings and revenue estimates and raising its full-year profit outlook. Read more.

Abbott stock jumped early Thursday on better-than-expected second-quarter metrics. The company also raised its profit view.

Abbott Laboratories (ABT) is currently at $99.59, up $10.32 or 11.56%